Irizarry MC, Fleisher AS, Hake AM, Liu P, Shcherbinin S, DeMattos RB, Mintun MA, I5T‐MC‐AACG investigators. P4‐388: Trailblazer‐Alz (Nct03367403): A Phase 2 Disease‐Modification Combination Therapy Trial Targeting Multiple Mechanisms of Action Along the Amyloid Pathway. Alzheimer's & Dementia, July 2006
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.